Kazakhstan vs Western Pacific (WHO region): Cases started on MDR-TB treatment

Kazakhstan
4,641
in 2024
Western Pacific (WHO region)
34,878
in 2024
Kazakhstan rank
7th
Western Pacific (WHO region) rank
6th

Cases started on MDR-TB treatment over time

  • Kazakhstan
  • Western Pacific (WHO region)
010.0k20.0k30.0k40.0k200520142024

How they compare

Western Pacific (WHO region) currently reports 34,878 against 4,641 in Kazakhstan, a difference of 30,237.

That makes Western Pacific (WHO region)'s figure about 7.5 times Kazakhstan's.

The two have swapped places 1 time across 16 shared years of data; in 2009 it was Kazakhstan ahead.

Kazakhstan ranks 7th and Western Pacific (WHO region) ranks 6th of 193 countries.

Across the 3 decades both report, Kazakhstan averaged higher in 1 and Western Pacific (WHO region) in 2.

Head to head by decade

Decade Kazakhstan Western Pacific (WHO region) Difference Ahead
2000s 3,209 1,449 1,760 Kazakhstan
2010s 6,228 13,760 7,532 Western Pacific (WHO region)
2020s 4,665 32,164 27,499 Western Pacific (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cases started on mdr-tb treatment, Kazakhstan or Western Pacific (WHO region)?
Western Pacific (WHO region), at 34,878 against 4,641 in Kazakhstan as of 2024.
What is the difference in cases started on mdr-tb treatment between Kazakhstan and Western Pacific (WHO region)?
30,237, with Western Pacific (WHO region) ahead.
How many years of comparable data are there for Kazakhstan and Western Pacific (WHO region)?
16 years are reported by both, from 2009 to 2024.
How do Kazakhstan and Western Pacific (WHO region) rank globally for cases started on mdr-tb treatment?
Kazakhstan ranks 7th and Western Pacific (WHO region) ranks 6th of 193 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Kazakhstan vs Western Pacific (WHO region): Cases started on MDR-TB treatment. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 05 September 2026, from https://health.statizoid.com/compare/cases-started-on-mdr-tb-treatment/kazakhstan/western-pacific-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/cases-started-on-mdr-tb-treatment/kazakhstan/western-pacific-who-region/">Kazakhstan vs Western Pacific (WHO region): Cases started on MDR-TB treatment</a> — Statizoid

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,226 data points, 2005–2024
Last refreshed